Skip to main content
. 2020 Sep 1;9(21):7863–7878. doi: 10.1002/cam4.3312

TABLE 5.

Standardized differences of baseline covariates before and after propensity score matching

Covariate Before PS matching ‐ means After PS matching ‐ means
BRAF/MEKi aPD‐1 Standardized difference a BRAF/MEKi aPD‐1 Standardized difference
Age at 1L initiation 61.118638 62.893807 0.124 61.397791 62.630218 0.055
BMI at 1L initiation 28.160065 28.091854 0.012 27.77051 27.504839 0.030
Deyo‐adapted Charlson Score 1.1574803 1.3209877 0.103 1.0619455 1.2157635 0.074
Brain metastases 0.3700787 0.2098765 0.359 0.3026492 0.282466 0.044
Lung metastases 0.496063 0.2839506 0.446 0.4578971 0.4458166 0.024
Liver metastases 0.3070866 0.0864198 0.578 0.2198274 0.20815 0.028
Bone metastases 0.2992126 0.2098765 0.206 0.3089958 0.3113862 0.005
Other metastases 0.7322835 0.5555556 0.376 0.6873984 0.639114 0.102
ECOG performance status 0‐1 0.5826772 0.7530864 0.368 0.6058463 0.5896688 0.033
ECOG performance status 2+ 0.2204724 0.0493827 0.517 0.1523432 0.1494931 0.008
ECOG performance status not documented 0.1968504 0.1975309 0.002 0.2418106 0.2608381 0.044
Stage at diagnosis III/IV 0.8267717 0.6296296 0.454 0.7199062 0.721749 0.004
Stage at diagnosis I/II 0.0866142 0.0740741 0.046 0.0767331 0.0789891 0.008
Stage at diagnosis not documented 0.0866142 0.2962963 0.553 0.2033607 0.1992619 0.010
Albumin result – low 0.3464567 0.1481481 0.472 0.2714096 0.2513166 0.046
Albumin result – normal 0.503937 0.7901235 0.628 0.6100672 0.632766 0.047
Albumin result ‐ not documented 0.1496063 0.0617284 0.289 0.1185232 0.1159174 0.008
Female 0.3543307 0.382716 0.059 0.3917868 0.3827421 0.019
Practice region ‐ South 0.5669291 0.5432099 0.048 0.5134602 0.5636567 0.101
Practice region ‐ West 0.3149606 0.2716049 0.095 0.2924953 0.2746459 0.040
Practice region ‐ Midwest 0.0708661 0.1111111 0.140 0.1267328 0.0757432 0.170
Practice region ‐ Northeast 0.0472441 0.0740741 0.113 0.0673117 0.0859542 0.070
Prior radiation 0.3700787 0.3703704 0.001 0.3939133 0.4177884 0.049
Prior surgery 0.6614173 0.7530864 0.202 0.7084217 0.711024 0.006
LDH result ‐ normal 0.3700787 0.5061728 0.277 0.4089619 0.3629776 0.095
LDH result ‐ elevated 0.2519685 0.1851852 0.162 0.2306331 0.2646264 0.079
LDH result ‐ not documented 0.3779528 0.308642 0.146 0.360405 0.372396 0.025
History of tobacco exposure 0.488189 0.5185185 0.061 0.5264428 0.5011438 0.051
History of tobacco exposure ‐ not documented 0.015748 0.0246914 0.064 0.0144088 0.0162188 0.015

Abbreviations: 1L, first‐line; aPD‐1, anti‐PD‐1 monotherapies; BMI, body mass index; BRAF/MEKi, BRAF/MEK inhibitors; ECOG, Eastern Cooperative Oncology Group; LDH, lactate dehydrogenase.

a

Any standardized difference of more than 0.2 suggests an balanced between the two groups.